APPLICATION
ANDA040708
TYPE
ANDA
ORIGINAL APPROVAL
2007-02-27
LATEST ACTION
2018-11-02
ROUTE
OROPHARYNGEAL, ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
LIDOCAINE HYDROCHLORIDE VISCOUSPrescription
LIDOCAINE HYDROCHLORIDE 2% · SOLUTION · ORAL
Approval history
2018-11-02Labeling · Supplement 7 · standardAP
2014-12-01Labeling · Supplement 6 · standardAP
2007-02-27OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.